N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.
作者信息
Schuff Norbert, Meyerhoff Dieter J, Mueller Susanne, Chao Linda, Sacrey Diana Truran, Laxer Kenneth, Weiner Michael W
机构信息
Magnetic Resonance Unit VA Medical Center, Department of Radiology, University of California, San Francisco, CA 94121, USA.
出版信息
Adv Exp Med Biol. 2006;576:241-62; discussion 361-3. doi: 10.1007/0-387-30172-0_17.
Abstract
摘要
相似文献
1
N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.
Adv Exp Med Biol. 2006;576:241-62; discussion 361-3. doi: 10.1007/0-387-30172-0_17.
2
Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis.
Neuroradiology. 2001 Jul;43(7):537-41. doi: 10.1007/s002340000521.
3
Evidence for cellular damage in normal-appearing white matter correlates with injury severity in patients following traumatic brain injury: A magnetic resonance spectroscopy study.
Brain. 2000 Jul;123 ( Pt 7):1403-9. doi: 10.1093/brain/123.7.1403.
4
Neuroanatomical correlates of depression in post traumatic brain injury: preliminary results of a pilot study.
J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):231-5. doi: 10.1176/jnp.2010.22.2.231.
5
In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of former prisoners of war with and without posttraumatic stress disorder.
J Neuropsychiatry Clin Neurosci. 2003 Summer;15(3):367-70. doi: 10.1176/jnp.15.3.367.
6
Brain creatine elevation and N-Acetylaspartate reduction indicates neuronal dysfunction in the setting of enhanced glial energy metabolism in a macaque model of neuroAIDS.
Magn Reson Med. 2011 Sep;66(3):625-34. doi: 10.1002/mrm.22821. Epub 2011 Mar 4.
7
Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5(3):141-9. doi: 10.1080/14660820410017109.
8
Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging.
Radiology. 2013 Jun;267(3):851-7. doi: 10.1148/radiol.13121148. Epub 2013 Jan 29.
9
Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Ann Neurol. 1994 Jul;36(1):40-7. doi: 10.1002/ana.410360110.
10
Proton MR spectroscopic findings correspond to neuropsychological function in traumatic brain injury.
AJNR Am J Neuroradiol. 1998 Nov-Dec;19(10):1879-85.
引用本文的文献
1
A Proton Magnetic Resonance Spectroscopy (H MRS) Pilot Study Revealing Altered Glutamatergic and Gamma-Aminobutyric Acid (GABA)ergic Neurotransmission in Social Anxiety Disorder (SAD).
Int J Mol Sci. 2025 Jul 18;26(14):6915. doi: 10.3390/ijms26146915.
2
Neurometabolite Changes After Transcranial Photobiomodulation in Major Depressive Disorder: A Randomized Controlled Trial Investigating Dose-Dependent Effects.
J Clin Med. 2025 May 13;14(10):3402. doi: 10.3390/jcm14103402.
3
Normal cerebral oxygen consumption and lactate levels in patients with Alzheimer's disease and Lewy body dementia.
Geroscience. 2025 Apr 24. doi: 10.1007/s11357-025-01658-x.
4
1H Nuclear Magnetic Resonance (NMR)-Based Metabolic Changes in Nucleus Accumbens and Medial Prefrontal Cortex Following Administration of Morphine in Mice.
Cureus. 2025 Mar 3;17(3):e79972. doi: 10.7759/cureus.79972. eCollection 2025 Mar.
5
Assessing the Relationship of Brain Metabolites to Cortical Thickness and Dementia Symptoms in Adults with Down Syndrome: A Pilot Study.
Brain Sci. 2024 Dec 11;14(12):1241. doi: 10.3390/brainsci14121241.
6
Assessment of Mannitol-Induced Chronic Blood-Brain Barrier Dysfunction In Vivo Using Magnetic Resonance.
Int J Mol Sci. 2024 Sep 10;25(18):9792. doi: 10.3390/ijms25189792.
7
N-acetylaspartate promotes glycolytic-to-oxidative fiber-type switch and resistance to atrophic stimuli in myotubes.
Cell Death Dis. 2024 Sep 19;15(9):686. doi: 10.1038/s41419-024-07047-0.
8
Radiation-Induced Cognitive Decline: Challenges and Solutions.
Cancer Manag Res. 2024 Aug 21;16:1043-1052. doi: 10.2147/CMAR.S441360. eCollection 2024.
9
Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer's disease through multi-omics analysis.
Front Microbiol. 2024 Jul 9;15:1440564. doi: 10.3389/fmicb.2024.1440564. eCollection 2024.
10
Deep mutational scanning reveals a correlation between degradation and toxicity of thousands of aspartoacylase variants.
Nat Commun. 2024 May 13;15(1):4026. doi: 10.1038/s41467-024-48481-0.
本文引用的文献
1
Metabolic characteristics of cortical malformations causing epilepsy.
J Neurol. 2005 Sep;252(9):1082-92. doi: 10.1007/s00415-005-0819-7. Epub 2005 Apr 29.
2
Magnetic resonance detects brainstem changes in chronic, active heavy drinkers.
Psychiatry Res. 2004 Dec 30;132(3):209-18. doi: 10.1016/j.pscychresns.2004.06.003.
3
Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites.
Alcohol Clin Exp Res. 2004 Apr;28(4):650-61. doi: 10.1097/01.alc.0000121805.12350.ca.
4
Identification of abnormal neuronal metabolism outside the seizure focus in temporal lobe epilepsy.
Epilepsia. 2004 Apr;45(4):355-66. doi: 10.1111/j.0013-9580.2004.27603.x.
5
Reduced extrahippocampal NAA in mesial temporal lobe epilepsy.
Epilepsia. 2002 Oct;43(10):1210-6. doi: 10.1046/j.1528-1157.2002.10802.x.
6
Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus.
Neurology. 2002 Jun 11;58(11):1635-41. doi: 10.1212/wnl.58.11.1635.
7
Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.
Neurology. 2002 Mar 26;58(6):928-35. doi: 10.1212/wnl.58.6.928.
8
Separate and interactive effects of cocaine and alcohol dependence on brain structures and metabolites: quantitative MRI and proton MR spectroscopic imaging.
Addict Biol. 2001 Sep;6(4):347-361. doi: 10.1080/13556210020077073.
9
1H MRSI predicts surgical outcome in MRI-negative temporal lobe epilepsy.
Neurology. 2002 Mar 12;58(5):821-3. doi: 10.1212/wnl.58.5.821.
10
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease.
Neurology. 2001 Dec 26;57(12):2229-35. doi: 10.1212/wnl.57.12.2229.
Zotero 插件